T0	Participants 64 103	children with autism spectrum disorder.
T1	Participants 488 572	74 children with ASD with severe maladaptive behaviour and increased urinary I-FABP.
T2	Participants 573 651	Subjects were randomised to receive gluten-casein or a placebo for seven days.